Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes in Women Undergoing Dilation and Evacuation

Prophylactic tranexamic acid has shown been shown to reduce maternal mortality from postpartum hemorrhage with no adverse effects, but has not been studied to reduce bleeding complications with dilation and evacuation (D&E). We propose a randomized, double-blinded, placebo-controlled pilot study to determine whether routine use of intravenous (IV) tranexamic acid will decrease the need for interventions to control bleeding at the time of D&E at 16 to 24 weeks gestation.

Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes in Women Undergoing Dilation and Evacuation

Recruitment

Summary

Participation Requirements

Description

Tracking Information